Cochlear Hearing Loss Clinical Trial
Official title:
A Comparison of Conventional Hearing Aid Processing (CP) and Non-linear Frequency Compression (NLFC) Processing in Adult Patients With and Without Cochlear Dead Regions Who Have a Moderate to Severe Sensorineural Hearing Loss.
The investigators are interested in an additional hearing aid feature called non-linear
frequency compression (NLFC). This aims to improve audibility of high frequency sounds by
converting them into lower frequencies and has been shown to benefit those with
moderate-severe sensorineural hearing loss (SNHL). Cochlear dead regions (DRs) are areas of
the inner hearing organ (the cochlea) where there is little or no function and are commonly
found in regions responsible for detecting high pitched (frequency) sounds.
Not all people with hearing loss have DRs. The investigators would like to determine whether
based on the presence or absence of DRs, patients with moderate-severe SNHL perform better or
prefer their hearing aids programmed conventionally, or with NLFC activated. To do this, two
participant groups will be created based on findings from the threshold equalising noise
(TEN) test which identifies cochlear DRs. Two participant groups will be created; one group
with DRs and one group without DRs.
All participants will receive two hearing aids and will wear these programmed conventionally
for ~six weeks and with NLFC activated for ~six weeks in a counterbalanced manner. Following
each condition, participants will complete a questionnaire and various speech tests will be
performed. This involves participants repeating sentences, words or speech sounds they hear
from a speaker in quiet and in the presence of background noise. Individuals' scores will be
calculated for each test and their performance when NLFC was activated and deactivated will
be compared. This will be analysed alongside the questionnaire data to compare the 'DR' and
'no DR' group in both conditions. Findings may help to determine whether NLFC should be
activated for all moderate-severe SNHL patients, or just those with DRs, helping clinicians
to optimise hearing aid settings for patients.
Potential participants will be recruited from the audiology database at Manchester Foundation
Trust. Those who meet the inclusion criteria will be sent a letter in the post accompanied by
a participation information sheet to raise their awareness of the project. This criterion
includes those aged 45 and over with a bilateral moderate to severe sensorineural hearing
loss who wear two hearing aids. They must report to wear these for > 5 hours each day which,
will then be confirmed by their hearing aid data logging. English must be their first
language due to the test material that will be used.
Patients will be provided with a participant information sheet, outlining what will happen in
each of the four sessions and a consent form. This participant information pack will inform
potential participants about how they may indicate their interest or contact the researchers
for more information about what the study entails. The investigators will try and recruit 30
participants in total to allow for attrition in the event of withdrawal or exclusion from the
study. The researchers hope to find 24 (12 in each group) eligible participants who will be
able to complete the study. The researchers anticipate recruitment will be done over one
month and data collection over four. It is possible that participants may be excluded from
the study once testing begins if asymmetrical DRs are found (present at frequencies < 3kHz in
one ear only) or any otological symptoms arise that prevent participants from wearing their
aids for >5 hours a day. The sample size was taken based on pragmatic ground and time
constraints as this is a MSc project.
Participants who provide written, informed consent will attend a reassessment appointment
(session one) a fitting appointment (session two) and a follow up appointment (session
three). These appointments are routinely offered to all patients who are beginning a new
hearing aid pathway. Additionally, the researchers are asking participants to attend one
further follow up appointment (session four). Each session will last between one and one and
a half hours.
Session One- A reassessment is routinely offered to patients every three years and involves;
- A brief medical history to identify potential ototoxic medication, any otological
symptoms and factors which may impact patient's ability to manage hearing aids.
- Establishing the patient's hearing aid history to determine use and understand the
patient's lifestyle.
- Otoscopy (where the clinician will look in the ears) and tympanometry (where the
clinician will assess the ear drums).
- A pure tone audiogram (PTA) to determine the patient's hearing thresholds.
- If required, impressions of the ears will be taken for new earmoulds to be made.
Additionally, a TEN test will be performed in session one to assess for DRs. The TEN test
procedure is similar to that of a standard PTA but involves ipsilateral masking. This
prevents signal tones from being detected at other regions of the cochlea that surround the
DR. By preventing off-frequency/place listening, a DR can be detected. Based on findings from
the TEN test, participants will be split into two groups; those with significant bilateral
cochlear DRs < 3kHz (the DR group) and those without cochlear DRs or a DR > 4kHz (the no DR
group). Those with unilateral DRs < 3kHz will be excluded.
Session two- During session two, all participants will be familiarised with the test material
that will be used in sessions three and four. The adaptive Bamford Kowal Bench (BKB)
English-language sentences, the Arthur Boothroyd (AB) word list and auditory speech sounds
evaluation (ASSE) are all routine speech tests readily available within our audiology
department. These will be the speech tests used to measure performance with NLFC and with CP.
All testing will take place in a soundproof booth. None of these intensities should be too
loud for participants as they aim to replicate normal conversational levels. Following any
complains of loudness discomfort, the dB SPL will be reduced, and this will be recorded. The
questionnaire used will be The SSQ12, a validated shortened version of the speech, spatial
and qualities of hearing scale (SSQ) questionnaire that asks participants about their
listening experiences in various situations. The SSQ12 will be shown to participants in
session two, so they are aware of the situations they should be monitoring whilst wearing
their hearing aids.
BKB sentences will be played in the presence of noise presented at 55 A- weighted decibels
(dBA) and the speech level adapts depending on whether the participant repeats the sentence
correctly, or not. If two or more key words are repeatedly correctly, the response is
considered correct. Following two correct responses, the speech intensity will be decreased.
Following one incorrect response, the intensity of the signal will be increased. Participants
will be given a score in dB which corresponds to the intensity level at which 71% of the
sentences are correctly identified. The speech signal will always be presented from the front
(0° azimuth). The noise signal will be presented from the front, from the left (-90°
azimuth), and from the right (90° azimuth). One sentence list will be administered for the
noise presented at 0°, +90° and -90° and an average overall score in dB will be calculated.
The AB word list will be performed in the absence of background noise. Words will be played
from a loudspeaker at 65 decibels sound pressure level (dB SPL). The test material consists
of ten words per list and each word is made of three phonemes. A point is awarded for each
correct phoneme (0,1,2,3) and the average score from three lists will be calculated.
Additionally, participants will complete a phoneme discrimination task, ASSE at a level of
70dB SPL. They will be asked to discriminate between various phoneme pairs by a 'same/
different' procedure. Following three to eight presentations of a single speech sound,
another speech sound will be played e.g. V-Z. If participants respond correctly to two out of
three presentations, it can be concluded that the contrast between the background phoneme and
the odd speech sound is well discriminated and this will be marked as correct. Seven pairs
will be used, and participants will be given a percentage score based on how many they are
successfully able to discriminate between.
Also, during session two, participants will be fitted with bilateral Phonak Auto hearing
aids. These will be programmed to NAL-NL2 prescription targets following departmental
protocol and British Society of Audiology (BSA) recommended procedures, which includes making
real ear measurements (REMs). NLFC will be programmed into all participants hearing aids but
will be deactivated in half of the participants from each group in a randomised manner. This
will be generated for each group separately as there will be 12 participants in the 'DR
group' and 12 in the 'no DR group'. Using an Excel formula, participants in each group will
be placed in a random order in a list. The first six participants listed in each group will
experience NLFC first. The remaining six participants listed in each group will experience CP
first. Participants will be unaware of how their aids are programmed. NLFC in the 'no DR'
group will be validated according to BSA recommended procedures. NLFC in the 'DR group' will
be set based on where their dead region begins. This will be set at 0.75 times their
individual edge frequency (0.75Fe). Any fine tuning requested by participants of the hearing
aids will be permitted up to 7 days following fitting.
Session three- Around six weeks after the first fitting, session three will take place. This
will consist of testing participants with their hearing aids set to their first condition
using the adaptive BKB sentence test, AB word list and ASSE, as outlined above. Participants
will also complete the SSQ12 in an interview style format. Following this, the participant's
hearing aid settings will be swapped to the opposite condition i.e. if NLFC was activated in
session two, this will be disabled in session three and vice versa. Any fine tuning requested
by participants of the hearing aids will be permitted up to 7 days following fitting.
Session four- Around six weeks later, session four will take place. This will involve testing
participants with their hearing aids set to their second condition using the same test
material and completing the same questionnaire as in session three. Participants will then be
given a choice of which setting they would like permanently or can decide to go away with
both settings programmed into the hearing aids and decide at a later date.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
Withdrawn |
NCT04041596 -
Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook
|
Phase 4 | |
Recruiting |
NCT04610112 -
PMCF on Safety and Performance of HiResTM Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
|
||
Completed |
NCT04610216 -
Investigation of the Automatic Technology on the Naída M Hearing Devices
|
||
Completed |
NCT03288753 -
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
|
N/A | |
Completed |
NCT03248856 -
Triamcinolone Levels in Cochlear Perilymph
|
Phase 1 | |
Completed |
NCT04048239 -
Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation
|
N/A | |
Completed |
NCT04815343 -
Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
|
N/A | |
Recruiting |
NCT06114680 -
Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy
|
N/A | |
Completed |
NCT03756337 -
Neuro 1 vs. Neuro 2 Sound Processors
|
N/A | |
Completed |
NCT04120181 -
A New Predictor Marker for Cochlear Implants Infection
|
||
Terminated |
NCT05586555 -
A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings
|
N/A | |
Recruiting |
NCT04929470 -
Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
|
||
Completed |
NCT04183348 -
Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss
|
N/A | |
Not yet recruiting |
NCT06420921 -
MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE
|
N/A | |
Completed |
NCT06235073 -
Robotic and Manual Cochlear Implantation: An Intra-individual Study of Speech Recognition and Electrode Holder Position (ICRobMan)
|
||
Recruiting |
NCT05486637 -
Vocal Emotion Communication With Cochlear Implants
|
Early Phase 1 | |
Recruiting |
NCT06301581 -
Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
|
||
Recruiting |
NCT06301568 -
Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation
|
||
Withdrawn |
NCT04651660 -
Using Electrocochleography During Cochlear Implantation of the Neuro Zti.
|
N/A |